Thoraflex Hybrid Prosthesis (THP): the profile.
Expert Rev Med Devices
; 21(3): 165-177, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-38431273
ABSTRACT
INTRODUCTION:
With the incidence of thoracic aortic disease on the rise, total arch replacement (TAR) with frozen elephant trunk (FET) remains the gold-standard management strategy due to optimal results. Several FET devices exist commercially on the global market. However, the mainstay and most commonly used and reported device is the Thoraflex Hybrid Prosthesis (THP), with several recent reports suggesting its superiority. AREAS COVERED This review aims to collate and summarize the evidence in the literature on the clinical outcomes of TAR with FET using THP, with a focus on mortality, neurological complications, endoleak, distal stent-induced new entry (dSINE), aortic remodeling, coagulopathy, and graft kinking. In addition, the design features of THP is discussed, and an overview of market competitors is also highlighted. EXPERT OPINION THP consistently demonstrates its effectiveness in treating complex thoracic aortic pathology through favorable clinical outcomes, which can be attributed to its unique and innovative design. Rates of early mortality ranged 0.6-14.2%, neurological complications 0-25%, endoleak 0-8.4% and dSINE 0-14.5%, with minimal incidence of graft kinking and coagulopathy. Aortic remodeling is favorable and comparable to competitors. All this evidence solidifies THP as the leading FET device, particularly when combined with appropriate patient selection and surgical planning.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Blood Vessel Prosthesis Implantation
/
Aortic Dissection
Limits:
Humans
Language:
En
Journal:
Expert Rev Med Devices
Journal subject:
DIAGNOSTICO POR IMAGEM
/
TERAPEUTICA
Year:
2024
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom